The New Public Health and STD/HIV Prevention (PDF)

Sevgi O. Aral, MA, MS, PhD, has been the Associate Director for Science in the Division of STD Prevention, Centers for Disease Control since 1993.  She holds professorial appointments at the University Of Washington in Seattle; University of Manitoba in Winnipeg and Emory University in Atlanta. Dr. Aral has authored more than 230 scientific articles and edited 16 journal issues and 2 books.  Dr. Aral has served on many national and international work groups, boards and committees; and has consulted for the World Health Organization, The European Union and the World Bank.  She has received the ASTDA Achievement Award and the Thomas Parran Award. Over the years, her research interests have included social and behavioral aspects of sexually transmitted disease epidemiology and prevention; including gender, age and race effects; mixing patterns; sexual and social networks; contextual factors; social determinants and most recently, program science. Dr. Aral came to the Centers for Disease Control in 1978 from Middle East Technical University in Ankara, Turkey where she was the chair of the Department of Social Sciences.



Kevin Fenton, MD, PhD, FFPH, is the Director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC), a position he has held since November 2005. Previously, he was chief of CDC's National Syphilis Elimination Effort and has worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Before coming to CDC, he was the Director of the HIV and STI Department at the United Kingdom's Health Protection Agency. At CDC, Dr. Fenton has led a number of critical efforts to address the U.S. HIV epidemic, including the release of revised HIV screening recommendations to make HIV testing a routine part of medical care for all Americans, and the implementation of a new surveillance system to provide more precise estimates of new HIV infections in